Evidence map›Paper›PMID 28932314›Full record

ArticleOpen access Macedonian journal of medical sciences2017

Cost-Effectiveness Analysis of Treatment Acute Deep Vein Thrombosis in Clinic of Vascular Surgery Sarajevo.

Haris Vukas, Samra Kadić-Vukas, Adis Salihbegović, Muhamed Djedović, Dragan Totić, Haris Vranić, Amel Hadžimehmedagić

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Haris VukasClinic of Vascular Surgery Sarajevo, Clinical Centre University of Sarajevo, Čekaluša 88, Sarajevo, Bosnia and Herzegovina.
Samra Kadić-VukasDepartment of Neurology Cantonal Hospital Zenica, Crkvice 76, Zenica, Bosnia and Herzegovina.
Adis SalihbegovićInstitute of Forensic Medicine and Forensic Toxicology Medical Faculty in Sarajevo, Čekaluša 90, Sarajevo, Bosnia and Herzegovina.
Muhamed DjedovićClinic of Vascular Surgery Sarajevo, Clinical Centre University of Sarajevo, Čekaluša 88, Sarajevo, Bosnia and Herzegovina.
Dragan TotićClinic of Vascular Surgery Sarajevo, Clinical Centre University of Sarajevo, Čekaluša 88, Sarajevo, Bosnia and Herzegovina.
Haris VranićClinic of Vascular Surgery Sarajevo, Clinical Centre University of Sarajevo, Čekaluša 88, Sarajevo, Bosnia and Herzegovina.
Amel HadžimehmedagićClinic of Vascular Surgery Sarajevo, Clinical Centre University of Sarajevo, Čekaluša 88, Sarajevo, Bosnia and Herzegovina.
University of Sarajevo · BAUniversity of Zenica · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo compare hospital costs of acute deep vein thrombosis (ADVT) treatment in two periods of time. Evidence of repercussions on reducing costs during successful treatment. Attention was given to the necessity, costs and effectiveness of diagnostic procedures, treatment and complications.

methodsA retrospective analysis of data obtained from patients medical history in a period from 2000 to 2016. Model management and safe practice of ADVT care consisted of clinical examination, laboratory, colour Doppler and invasive diagnostics. In a treatment was used continuous infusion un-fractionated heparin for 40 patients from 2000th till 2006th and low molecular weight heparin for 40 patients from 2006th till 2016th. All patients were converted to oral anticoagulants.

resultsWhen we look at the overall picture of improving the management model, safe practices and economic rationalization, we conclude that we offer better health service for the patients with ADVT at the moment, which relies on proven medical treatment trends. While we do not forget responsibility towards a society of which depends on treatment funding.

conclusionThe implementation of a conceptually new model of management of ADVT did not contribute rise of the desired outcomes, but it justified the positive economic viability of introduced changes at the Clinic of Vascular surgery than the previous concept.

Indexed as

acute deep vein thrombosis (ADVT)costlow molecular weight heparin (LMWH)un-fractionated heparin (UFH)

Identifiers

PMID28932314
PMCPMC5591603
OpenAlexW2743393998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.